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Abstract 
 
 
 
Gonadotropin releasing hormone (GnRH) is secreted in rhythmic pulses every 1–2 hours. 
Disruption of this pulsatile release is associated with pathologies in reproductive function 
and sexual development. In order to approach an implantable, rhythmic delivery system 
for GnRH, a published prototype has been demonstrated that can generate rhythmic 
pulses of GnRH release in response to a constant glucose level. In this thesis, the 
prototype was altered with the intent to advance the development of a practical, 
implantable system.  First, the commercial pH stat was replaced by a self-assembled one. 
The customized pH-stat was suitable for most titration conditions. Second, the durability 
of the membrane used in the system was improved. Third, the ratio of the membrane 
surface to the volume of delivery system was increased to speed up the systems 
oscillatory behavior. While these modifications improved the practicality of the delivery 
system, it resulted in the lose of pulsatile release behavior, for unknown reasons. A 
systematic approach is suggested, which can reveal the root cause analysis of the failure. 
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Chapter 1 Introduction  
1.1 General Introduction 
 
Numerous endogenous hormones are known to be secreted in a pulsatile manner. For 
example, a neuroendocrine network controls reproduction and sexual development in 
mammals, where the release of hormones is not constant with time. An important 
reproductive hormone in human puberty and reproduction, gonadotropin releasing 
hormone (GnRH), is released in rhythmic pulses from the hypothalamus every 1–2 hours 
to stimulate secretion of luteinizing hormone (LH) and follicle stimulating hormone 
(FSH) in the anterior pituitary gland. GnRH subsequently degrades within a few minutes 
while the downstream signals carry out their actions in the human body. Disruption of 
this rhythm is associated with pathologies in reproductive function and sexual 
development. Central precocious puberty occurs when the GnRH pulse generator is 
initiated too early in development. Conversely, a developmental delay of GnRH release 
gives rise to delayed puberty [1]. Kallmann syndrome (KS) associated with anosmia, will 
also present if GnRH secretion is reduced [2]. KS is diagnosed in about 1 in 30,000 males 
and 1 in 120,000 females. Additionally, depressed GnRH secretion increases the risk of 
osteoporosis in both man and woman. To mitigate the pathologies associated with GnRH 
depression, several strategies involving GnRH release have been pursued [3-5]. Any such 
strategy must restore not only appropriate levels of GnRH but also their pulsatility. 
1.2 Background 
Several administration routes, including external controlled subcutaneous pumps [6], 
transdermal iontophoretic delivery [7] and intranasal sprays [8], have been investigated 
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for GnRH release stimulation. However, the electroporation route was only investigated 
at room temperature [6]. The transdermal iontophoretic route may be burdensome for the 
patient [7]. Intranasal administration was tested in several volunteers, but raised estrogen 
levels and breakthrough bleeding were reported [8]. 
In considering an implantable, rhythmic delivery system for GnRH, it is helpful to 
examine studies that addressed the pulsatile delivery of other drugs. Magnetic 
nanohydrogels were designed to respond to pulsed magnetic fields [9]. Ca-alginate gel 
beads were prepared for pulsatile dextran release. The use of various bead diameters 
produced different time intervals for dextran release [10].  However, only a limited 
number of pulses are possible with this formulation. Multi-layered capsules with 
biodegradable layers between drug layers were proposed, but could not be realized due to 
manufacturing difficulty [11].  
We propose to construct a hormone release system, which can produce pulsatile drug 
delivery in response to endogenous stimuli, such as plasma glucose (Figure 1.1). It is 
noteworthy, that this system will generate rhythmic pulses of GnRH release, even though 
the blood glucose concentration remains constant. This is in contrast to system that 
deliver pulses of insulin in response to changes in blood glucose level [12]. 
So as to release the high potency and low dose GnRH, a previous hydrogel-enzyme based 
system (Figure 1.2) was achieved [13-16]. Previous publication demonstrated that under 
proper conditions, the system exhibits rhythmic pulsed GnRH release with internal pH. 
 
 3 
 
Figure 1.1 Rhythmic pulsatile GnRH release profile in the present if blood glucose level 
constant. [13] 
 
Figure 1.2 Schematic of glucose-driven drug delivery system. a) A published prototype of 
a glucose driven chemical pH oscillator. b) Enzymatic metabolism of glucose molecules 
in Cell II. [14] 
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Figure 1.2 a) is a schematic diagram of a benchtop prototype for a drug delivery system 
that is capable of releasing drug in a rhythmic, pulsatile manner. Cell I represents the 
circulation, which provides a steady input of glucose and allows “waste removal” from 
the system.  Cell I is well stirred and maintained at 37 °C by a water jacketed beaker, and 
is also pH-controlled at 7.0.  Cell I is constantly fed with an aqueous glucose solution of a 
specified concentration, prepared at pH 7.0, with an ionic strength of 50 mM by addition 
of NaCl. Cell II also contains 50 mM NaCl aqueous solution along with enzymes glucose 
oxidase (GluOx), gluconolactonase (GluLac), and catalase (Cat).  Like Cell I, Cell II is 
well stirred and maintained at 37 °C.  Finally, Cell II contains a piece of marble (CaCO3).  
Cells I and II are separated by a hydrogel consisting of poly(N-isopropylacrylamide-co-
methacylic acid) (NIPA/MAA), crosslinked with methylenebisacrylamide (BIS).  As 
discussed in Chapter 3, this membrane is charged, swollen and permeable to glucose and 
to drug, when Cell II is at high pH, but is uncharged, collapsed and impermeable to 
glucose and drug with Cell II is at low pH.  Cell II plus the membrane together form the 
prototype drug delivery system. 
The proposed mechanism for the control of drug release is explained as follow. For this 
pulsatile, cyclic process, it can be initially assumed that the membrane is in the charged, 
swollen state.  As such, glucose from Cell I will permeate the membrane into Cell II, 
where it is rapidly reacted with oxygen, due to enzyme catalysis (reaction summarized in 
Fig. 1.2 b). Hydrogen ion (H+) and gluconate anion are products that cause a lowering of 
pH in Cell II.  The hydrogen ion then diffuses into the membrane, and neutralizes the 
negatively charged, pendant carboxylate groups on the methacrylate polymer.  
Eliminating the electrostatic repulsion causes the hydrogel membrane to collapse.  In the 
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collapsed state, the membrane blocks glucose entry, and production of H+ is attenuated.  
Eventually, the hydrogen ions in the membrane diffuse into Cell I and the hydrogel ion in 
Cell II is neutralized by the marble, causing pH in Cell II to rise. In a time dependent 
manner, determined by the properties of the membrane and cell conditions, the pH in Cell 
II rises enough for the membrane to revert back to its swollen state, and glucose can re-
enter Cell II, restarting the cycle.  As the membrane goes through cycles of swelling and 
collapse, it alternatively permits and blocks drug release, giving rise to rhythmic, 
pulsatile release behavior. 
The previous description is ideal, insofar as it assumes that the membrane is either 
permeable to glucose or is completely impermeable.  In fact, even in the collapsed state, 
the membrane exhibits a small but nonzero permeability to glucose.  Hence, the 
oscillatory behavior will not occur for all glucose concentrations in Cell I.  Specifically, if 
the glucose concentration is too low, then the rate of H+ generation in Cell II will be too 
slow to cause sufficient neutralization for membrane collapse, and the membrane will 
remain in a swollen state.  On the other hand, if glucose concentration in Cell I is too 
high, then there will be sufficient flux of glucose into Cell II to allow continuous 
production of H+ and permanent collapse of the membrane. Thus, oscillations will only 
occur in response to a range of glucose concentrations in Cell I. 
Early experiments showed that this system, in the absence of marble in Cell II, slowly 
evolved to a steady state of intermediate pH in Cell II and intermediate permeability to 
glucose.  When marble was added and glucose concentration in Cell I was increased, pH 
oscillations in Cell II were observed, as was rhythmic pulsed release of drug.  Marble has 
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the effect of consuming H+ by the reaction 2H++CaCO3→Ca2++CO2+H2O.  This 
consumption amounts to increased “clearance” of H+ from Cell II, and a higher “rate 
constant” for a change of H+ concentration, i.e. pH in Cell II can change more rapidly.  
Such rapid pH changes appear to be necessary to prevent the membrane from relaxing 
into a state of intermediate permeability. 
In this thesis, the goal was to convert the in vitro prototype, pulsatile device into a system 
that can be practically implanted and provide pulsatile drug delivery. There are three key 
aspects that were addressed.  First, we sought to replace the commercial pH-stat that we 
used, which was purchased commercially and is quite expensive, with a home-built 
device.  Second, a nanoclay crosslinker was evaluated as a replacement for the organic  
BIS crosslinker in the hydrogel membrane to achieve improved membrane durability.  
Third, the ratio of the membrane surface to the volume of Cell II was increased in an 
effort to eliminate the need for marble, which would provide an alternative means to 
increase the “clearance” of H+, and hence the rate constant for change in pH in Cell II. 
Additionally, we wish to optimize glucose-driven oscillation concentration at body 
glucose level by reducing the membrane thickness to enhance glucose permeability. 
1.3 Overview of the Thesis 
Chapter 1, this chapter, presents a brief review of the medical problem of interest, several 
pharmaceutical approaches to date and a brief review of a rhythmic delivery system 
prototype which we hope to improve. Chapter 2 provides the working principle of a 
customized pH stat as well as associated experiments used in its evaluation. Chapter 3 
contains the characterization of the primary material, pH-sensitive hydrogel, for the 
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delivery system, with an emphasis on the properties related to device performance.  The 
integrated, new prototype delivery system is described in Chapter 4, along with evidence 
addressing the performance of the system. Optimization methods and future direction is 
summarized in Chapter 5. 
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Chapter 2 pH Stat  
2.1 Introduction 
A pH stat is a control system for maintaining the pH of a solution at a specific 
experimental set point. Commercially available pH stats are costly and lake the design to 
maintain a constant volume. As a result, we chose to construct our own pH stat with 
Raspberry Pi, a single board computer programmable for specialized experimental use. In 
order to customize the control system to our needs, we have applied several methods to 
adjust the machine and compared the reliability among them. The final pH stat was able 
to perform well during our experiments, despite some minor drawbacks. 
2.2 Materials and Methods 
2.2.1 pH Stat 
The pH-stat programmed by Raspberry Pi (Monkmakes) consists of a probe to measure 
the pH of the solution and two peristaltic pumps to dose acid or base to maintain the pH 
of the solution at the target value. We assembled the pH stat (Figure 1.1) by fitting a 
RasPiRobot Board V3 (RRB3) on a Raspberry Pi computer board. The Raspberry Pi 
board is also connected to a power source, a monitor, a mouse, and a keyboard to enable 
basic commands and data output. The RRB3 is connected to a pH circuit and probe to 
measure pH. Peristaltic pumps are also activated by the RRB3 to make pH adjustments 
by pumping into or draining solution into or from the experimental environment.  
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Figure 2.1 Assembly of the pH stat. Different line styles represent cables. The dashed line 
and solid line stand for negative and positive terminals, respectively. 
Connecting cables in the reverse order cause the motors to run in the opposite direction; 
the directions can also be modulated by the computer code. Other external devices, such 
as the power source and keyboard, are displayed as text.  
2.2.2 Peristaltic Pumps  
The peristaltic pumps (Williamson) alternate compression and relaxation of tubing to 
transport the desired amount of solution into and out of the experimental environment 
(Figure 2.2). The motor-operated rollers pump solution through the tubing to deliver the 
microscale volumes that are necessary for our study. We chose a pump with four rollers 
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and 0.8mm diameter silicon tubing to achieve a slow enough fluid flow rate in order to 
deliver volumes as small as 0.05 mL/min. 
 
Figure 2.2 Work principle of peristaltic pump [17]. 
2.2.3 Raspberry Pi 
Raspberry Pi (Figure 2.3) is a credit-card sized computer that works with a monitor, 
keyboard, and mouse to program experiments. NOOBS is the official operating system 
for all models of Raspberry Pi. Customization of Raspberry Pi is conducted through 
Python codes as shown in the following sections. NOOBS allows Wi-Fi internet 
connection to share experimental data with a computer.
 
Figure 2.3 Raspberry Pi board with detailed input and output instructions [18]. 
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2.2.4 RasPiRobot Board 
The RasPiRobot board V3 (RRB3) (Figure 2.4) powers the Raspberry Pi and controls the 
motor function of the pH stat. The board fits right on the Raspberry Pi's GPIO socket. 
The RRB3 charges the motors on the peristaltic pumps to control the speed and direction 
of the pumping motion.  
 
Figure 2.4 RasPiRobot board detailed part instruction [19]. 
2.2.5 pH Meter 
The EZO pH circuit (Atlas scientific, Figure 2.5) is a pH sensor wired with RRB3 and a 
pH probe to read and write the pH data file. It snaps into the breadboard. The EZO pH 
circuit enables measurement from 0.001 to 14.000 with ± 0.002 pH unit accuracy.  
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Figure 2.5 EZO pH circuit specifications [20]. 
A double junction, glass micro pH electrode (Thermo scientific) was connected to the 
EZO circuit by a BNC connector. The pH probe and EZO circuit work together as the pH 
meter. 
2.3 Working Principle 
The pH stat is controlled by several Python code packages. We used the following code 
packages listed below to control the pH stat. The code can be adapted to suit specific 
project environments and exercise better control in different projects.  
2.3.1 pH Meter 
The following manual commands are run in Raspberry pi terminal drive to call the pH 
meter and activate data input and output. Once the pH probe reads the data from the 
experimental solution, Raspberry Pi generates a “pH.txt” file under the installed package 
folder for data analysis [21]. 
Sudo python i2c1.py                      #open pH meter work file 
Address,99                                 #tell EZO pH circuit communicate with the Raspberry Pi  
Poll, “n”                                            # read pH data every “n” second  
Control+C                                    # stop reading pH 
cal,low/mid/high,“x”                  #calibration pH meter with three different buffers. “x” is  
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                                                                   the calibration midpoint 
2.3.2 Peristaltic Pump 
1. Working Principle of the Motor 
The actions of the two motors in the peristaltic pump are directed by the following 
Python code. The motor rate is calculated for each motor as the volume extracted per unit 
time. The left motor runs with an arbitrary speed scale setting of 0.8 in clockwise 
direction, as indicated by “1”. The right motor has an arbitrary speed scale setting of 0.9 
in the counterclockwise direction and is indicated by “0”. The actual speed of arbitrary 
scale was calibrated to produce desired flow rate. Despite the different motor rates, the 
left motor and the right motor are able to deliver the same volume per unit time, 
0.5ml/min. This inconsistency is unfortunately due to the quality of the peristaltic pump. 
#establish connection to pump with 12 voltage total, 6 each 
from rrb3 import * 
import time 
rr = RRB3(12, 6) 
 
#Run motors (left motor with speed 0.8 in the clockwise direction, right motor with speed 0.9 in 
the counterclockwise direction) 
rr.set_motors(0.8,1,0.9,0)  
 
#Stop pumping when pumping time “n” is up 
time.sleep(“n”)  
rr.stop() 
 
2. pH Adjustment 
For pH adjustment, step 1 involves entering all the parameters into the code. The system 
was initially set with a targeted pH of 7.0 and initial solution volume of 150 mL. The pH 
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stat attempts to correct the system pH when it is either above the upper limit of 7.1 or 
below the lower limit of 7.0. The pH stat is programmed with 60 seconds of wait time to 
allow solution mixing before taking the next reading of system pH.  
When running Step 2, the pH file previously written by pH the meter will be read. Next, 
the “if loop” adjusts the pH when the pH is outside of the range of 7.0 to 7.1 [22]. For pH 
higher than 7.1, the program turns on the acid pump to supply acidic solution; the volume 
added is calculated by using a model to be described later. The volume of required acidic 
solution is translated into pumping time for the peristaltic pump with the equation of 
“pumping time=acid volume/ acid rate (0.5 ml/min)”. The peristaltic pump will then 
transport the acidic solution for the calculated amount of time to adjust the system pH. 
Similarly, for pH lower than 7.0, the program will calculate the volume and its 
corresponding pumping time, and then run the alkali pump for the desired amount of time 
to correct the pH back to the target pH. 
#Step 1: Call up file reader  
from watchdog.observers import Observer 
from watchdog.events import FileSystemEventHandler  
from rrb3 import * 
 
rr = RRB3(12, 6)  
lower_lim = 7.0                                      #lower pH set point 
upper_lim = 7.1                #higher pH set point 
init_volofsolution = 150                 #initial volume of solution 
set_pH = 7.0                                              #target pH of the experimental system 
base_pH = 11                                          #pH of base stock solution 
acid_pH = 6.0                  #pH of acid stock solution 
Mixing_time = 60                #waiting time in second for solution mixing  
 
import time  
 
#Step 2: Collect reading from the pH meter and record in log file 
class MyHandler(FileSystemEventHandler):) 
def on_modified(self, event): 
    logfile = open("/home/pi/Raspberry-Pi-sample-code/pH","r") 
    for line in logfile: 
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      pH = line 
      pH = pH.strip() 
      pH = float(pH) 
    print pH 
    logfile.close() 
 
#Step 3: Check if the measured pH is below the lower limit 
if pH < lower_lim: 
#Turn on pump supplying alkali with a speed of 0.4 in the counterclockwise direction 
         rr.set_motors(0.4,1,0,0))  
#Print added base volume  
print("Alkali_vol") 
print("Alkali_time") 
#Calculate volume needed to correct pH based on the acid-base equilibrium equation 
         alkali_vol = init_volofsolution*((10**set_pH)-
(10**pH))/((10**pH)+(10**(set_pH+alkali_pH+pH-14))) 
    alkali_rate = 0.5                        #Alkali solution supply rate 
    alkali_time = alkali_vol/alkali_rate     #Calculate pumping time 
    time.sleep(alkali_time)                  #Wait until pumping time is up 
    rr.stop()  
 
#Step 4: Check if the measured pH is above the upper limit     
          elif pH > upper_lim: 
#Turn on pump supplying acid 
rr.set_motors(0,0,0.5,0) 
    print("Acid_vol") 
    print("Acid_time") 
    acid_vol = init_volofsolution*((10**( pH-14))+(10**(-
set_pH)))/((10**(-acid_pH))-(10**(-set_pH))) 
    acid_rate = 0.5                          #Acid solution supply rate  
    acid_time = acid_vol/acid_rate           #Calculate pumping time 
    time.sleep(acid_time)                    #Wait until pumping time is up 
    rr.stop() 
 
 if __name__ == '__main__': 
 event_handler = MyHandler() 
 observer = Observer() 
 observer.schedule(event_handler, path='/home/pi/Raspberry-Pi-
sample-code/', recursive=False) 
 observer.start() 
 
The acid or base volume, Vacid or Vbase required to adjust to the target pH is calculated by 
the following acid-base equilibrium equation: 
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Where Vinitial is the initial volume. 
3. Modified pH Stat for the pH-Sensitive Hydrogel Project 
We modified the pH stat for our experiment with the hydrogel, where the experimental 
system would only become more acidic over time. As a result, only the base solution is 
needed to adjust the system pH back to the target. Additionally, we added a draining 
feature to the second pump in order to maintain a constant volume in the system. This is 
beneficial as it is easier to calculate titration using a constant volume. More importantly, 
the constant volume will exert constant pressure on the hydrogel, and thus the form and 
release profile will not be affected by any difference in water pressure. 
Step 3 and 4 were replaced by the following Python code for the purpose of the hydrogel 
influenced environment. When the measured pH is below the lower limit of 7.0, the 
program will calculate the volume and pumping time of base solution using the above 
acid-base equilibrium equation as mentioned above. The base solution will be pumped 
into the experimental system to adjust back to the target pH. Meanwhile, the pH stat 
generates a txt file listing of the volumes of base solution pumped each time and the 
duration of each pumping. Once the base solution mixes with the solution, the second 
pump will turn on to drain solution for the same amount of pumping time to remove 
excess solution from the system. The measure-and-pump cycle repeats throughout the 
experiment. 
# New step 3: Check if measured pH is below the lower limit 
if pH < lower_lim: 
# Calculate the volume of Alkali pumped and the pumping time 
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          alkali_vol = init_volofsolution*((10**set_pH)-
(10**pH))/((10**pH)+(10**(set_pH+alkali_pH+pH-14))) 
    alkali_time = alkali_vol/alkali_rate 
    print(alkali_vol) 
    print(alkali_time) 
 # Append pH and alkali volume data to log file                          
          f=open('/home/pi/Raspberry-Pi-sample-code/alkali_vol_data','a') 
    f.write(repr(pH)+repr(alkali_vol)+'\n') 
    f.close() 
#Turn on pump supplying alkali 
    rr.set_motors(0,1,0.9,1) 
    time.sleep(alkali_time) 
    rr.stop() 
# Wait until pumping time is up 
        time.sleep(Mixing_time) 
 
# New step4: Turn on draining pump to remove excess and keep volume constant 
    rr.set_motors(0.8, 1, 0, 1) 
    time.sleep(alkali_time) 
    rr.stop() 
# If pH is greater than or equal to the lower limit, then wait mixing time 
         else:(beginning of else statement, when if/then statement is 
‘false’ then to this) 
time.sleep(Mixing_time) 
 
2.3.3 Empirical Equation 
The aforementioned acid-base equilibrium equation is a theoretical equation that 
calculates the amount of acid or base solution needed for titration. However, we 
discovered that the equilibrium equation was not efficient for performing titration using 
the Raspberry Pi pH stat under most conditions. A slow titration is problematic as it 
would fail to properly mimic an in vivo, physiologic environment that maintains a 
constant pH. As a result, to accelerate the titration process, it is necessary to make some 
adjustments to the theoretical equilibrium equation. 
To obtain a new titration equation, we set up several pH points and titrated manually to 
obtain the exact volume needed. To be consistent with the experiment, the acidic 
solutions of different pH values consist of saline medium and hydrochloric acid (HCl) 
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stock solutions of various pHs to achieve a total volume of 150mL and final saline 
concentration of 50mM. The basic solution is a mixture of saline medium and sodium 
hydroxide (NaOH) stock solution with a pH of 11 and final saline concentration of 
50mM. The empirical curve of titration gives a regression equation that fits better for the 
experiment (Figure 2.6). The regression equation of volume needed for titration has pH 
as its only independent variable. 
 
Figure 2.6 The theoretical and empirical titration curve. 
1. The Polynomial Model 
The following polynomial equation has the better fitted regression for the data points.  𝑉"#$% = −0.4791 ∗ 𝑝𝐻1 + 8.9254 ∗ 𝑝𝐻6 − 56.359 ∗ 𝑝𝐻 + 121.36 
The R2 for polynomial regression is 0.99534. However, the polynomial equation 
produces negative values when the measured pH is between 6.9 and 7. The negative 
value keeps the pump running and leads to overcorrection. To address this problem, we 
included additional code to check on the calculated pumping time. If the pumping time is 
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less than zero, as a result of a negative volume calculated by the polynomial equation, the 
code will put a stop to the pump. 
 
Lower_lim = 7.0 
if pH < lower_lim: 
    alkali_vol = -0.4791*(pH**3)+8.9254*(pH**2)-56.359*pH+121.36 
    alkali_time = alkali_vol/alkali_rate 
# check if the calculated pumping time is negative 
      if alkali_time < 0: 
      alkali_time=0 
      else: 
      alkali_time=alkali_time 
 
This manual fix, however, means that the pump stops running even when the 
experimental pH is between 6.9 and 7, lower than the target 7. Therefore, the polynomial 
equation fails to correct the experimental pH back to 7, the target pH. 
2. The Exponential Model 
Given the significant drawbacks of the acid-base equilibrium equation and the 
polynomial equation, we plotted the data points using an exponential regression and 
obtained  𝑉"#$% = 5767.3 ∗ 𝑒:;.<=>∗?@ 
This equation will always produce a positive calculated volume for titration, which solves 
the problem of the polynomial model. This enables the pH stat to titrate with precision 
even when the system pH dips slightly below 7. 
It is worth mentioning that the exponential model does not perfectly align with the data 
points, especially when pH is lower than 5, which contributed to a lower R squared value. 
However, this is not a major concern, since during our experiment the pH never drops 
below 6. Additionally, we adjusted the Python code to apply a lower limit of 6.9, instead 
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of the original 7.0. The pH stat will stop titration as soon as the reading of experimental 
pH reached 6.9. This adjustment is unique to the exponential model to prevent overshoot. 
The exponential model returns a higher volume of solution needed for titration in 
comparison to the other equations. This can be particular problematic for small pH 
adjustments as low as 0.1 from the target. This is unfortunately an inherent downside of 
the exponential equation. To avoid overshooting, we found that setting the lower limit at 
6.9 reduces unnecessary pH fluctuation while achieving the target pH. 
 
lower_limit=6.9 
Import math 
 
if pH < lower_lim: 
    a = math.exp(0-(1.546*pH)) 
    alkali_vol = 5767.3*a 
    alkali_time = alkali_vol/alkali_rate 
    print(alkali_vol) 
    print(alkali_time) 
 
2.4 Results 
To test and compare the efficacy and efficiency among the acid-base equilibrium 
equation, the polynomial model, and the exponential model, we recorded the system pHs 
and time stamps using the Raspberry Pi pH stat for each model (Figure 2.7). Each 
measurement started with a solution of pH 5.65 (50mM saline and HCl). Then, the pH 
stat added a neutralizing solution of pH 11 (50mM saline and NaOH) to titrate the system 
pH to the targeted 7.0. The three equations were applied to each set up. The pH readings 
from the three models are compiled for comparison. 
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Figure 2.7 Comparison of three titration models, acid-base equilibrium equation, 
polynomial equation, and exponential equation. 
As shown in Figure 2.7, the exponential model is the first and only one to reach target pH 
of 7.0 in approximately 5 minutes. The pH of the system overshoots to around 7.2 and 
slowly returns back to 7.0 at 12 minutes. The polynomial model takes 10 minutes, twice 
as long, to reach pH 6.9. It cannot achieve pH 7.0 due to the “manual stop” on the pump 
for pH values between 6.9 and 7.0. The limitations on speed and lower than target pH 
make the polynomial model unsuitable for the pH stat. Lastly, the equilibrium equation 
reaches approximately pH 6.8 in 20 minutes when the recording terminates. Due to the 
slow pH adjustment, the equilibrium equation was also deemed unsuitable to code the pH 
stat. 
To test the responsiveness and stability of the pH stat using the exponential model, we 
introduced a low pH solution into the experimental solution and recorded the pH every 30 
seconds (Figure 2.8). The initial titration started with a 50mM saline solution of pH 5.7. 
In approximately 5 minutes, the experimental pH achieved the target pH 7. Between 5 
and 25 minutes, the measured pH fluctuated around 7. The pH stat was also able to raise 
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the pH back to 7 within 10 minutes when HCl was randomly added into the experimental 
system at 25,40, 50 and 62 minutes. 
 
 
Figure 2.8 Titration recovery stability test. The pH stat is programed with the exponential 
equation to perform titration. The system pH is plotted against time. 
The pH readings also revealed when the experimental solution was drained by the 
peristaltic pump. The plateaus at 3 to 5 minutes and 27 to 30 minutes represent paused 
titration when the solution mixes in the experimental system and the peristaltic pump 
drains the excess solution in the system to maintain relatively constant volume. The 
draining process might appear to slow down the titration because the pump delivering 
basic solution is programmed to pause. It is plausible to have both draining and delivery 
pumps work simultaneously to speed up the titration. However, the measured pH might 
not be accurate when the reading is taken with incomplete mixing. Therefore, it might be 
counterproductive to pump out nonhomogeneous solution mixture while basic solution is 
being added into the experimental system.  
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During the experiments with the hydrogel to be described in subsequent chapters , the 
donor chamber constantly releases hydrogen ions into the saline medium through the 
hydrogel, resulting in an increasingly acidic solution. To test the feasibility of applying 
the pH stat with the exponential model to maintain the pH under the real experimental 
environment, we set up a system that introduced buffers of various pH into the saline 
medium to create increasing acidity. The donor side was a small chamber filled with 3ml 
buffers of pH 3, 4, 5 and 6 that donated hydrogen ions into the rest of the system. The 
receptor side, containing 150ml of 50mM the saline medium, was regulated by the pH 
stat to maintain a pH of 7. The lower pH limit was set at 6.95 to avoid overshoot; the 
upper limit was set at 7.  
 
Figure 2.9 pH stability control tests. The pH stat is programmed with the experimental 
equation to neutralize four systems of hydrogen ion donors of pH 3, 4, 5 and 6. The 
system pH (blue line) and calculated volume of base solution (orange column) are plotted 
against time. 
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The pH stat successfully maintained the pH of solution to the targeted 6.95 to 7 range 
(Figure 2.9), with minimal fluctuation, when the donor solution’s pH was between 4 and 
6. When the donor side was more acidic (pH = 3), the pH stat was only able to maintain 
the pH between 6.8 to 6.9. The pH stat also recorded the small volumes, less than 0.01ml 
of base solution, added to correct the experimental pH. 
2.5 Discussion 
2.5.1 Evaluation of the pH Stat 
The components of the pH stat were inexpensive to acquire and easy to assemble and 
control. While commercially available pH controllers require less setup, the higher price 
may not justify their convenience. The pH controller introduced here can be adapted to 
most titration setups with calculation and hardware adjustment. The size of the pH 
controller we made is much smaller than that of the commercial product. 
The peristaltic pumps are suitable for accurate dosing applications. They are also 
adaptable to any volume or speed of solution for specific projects with different tubing 
and speed. The small pump size enables the pump to be secured on the same 7*6 inch 
circuit board as the Raspberry Pi.  
The high customizability of the pH stat also contributes to its drawback, the need for 
empirical modification for efficient performance. The following section addressed the 
empirical equations and modifications of the Python code. The delivery of smaller 
volumes can be challenging mainly due to the surface tension of the liquid and the tube 
diameter, which prevents drop detachment. Thus, in some cases, the small volumes are 
“saved” until the next triggered released into the system. Similar to other devices, the pH 
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stat requires regular calibration and monitoring. Additionally, because of its homemade 
nature, the pH stat has an unknown lifetime.  
2.5.2 Evaluation of the Empirical Equations 
The constants in the empirical equations, the polynomial equation and the exponential 
equation, were derived from experimental data to set up the pH stat. Both equations have 
the advantage of achieving faster titration than the acid-base equilibrium equation that is 
typically used in pH control systems.  
Interestingly, the titration data shows higher volume needed to achieve target pH than the 
theoretical volume calculated by the equilibrium equation. We suspect that this 
observation may have resulted from the titrated solution being in contact with air and the 
stirring. That is, the experimental setting allowed carbon dioxide from the air to dissolve 
in the solution, which converted to hydrogen carbonate and thus was also subject to 
titration.  
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Table 2.1 Comparison of the three models for titration. 
Characteristics  Base-acid equilibrium 
equation 
Polynomial 
equation 
Exponential 
equation 
Time to reach 
target 
Long Medium Short 
Accuracy  Exact Lower Exact 
Overshoot No No Yes 
Application Applicable to any system 
with some changes in 
parameters 
System specific System specific 
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Chapter 3 pH sensitive hydrogel 
3.1 Introduction 
Hydrogels are three-dimensional cross-linked networks with hydrophilic properties. 
Since Wichterle and Lim’s pioneering work on poly (2-hydroxyethyl methacrylate) 
(PHEMA) in 1960 [23], hydrogels have sparked interest in biomedical applications and 
drug delivery. Taking advantage of the high water content, softness, biocompatibility, 
and swelling-shrinking properties, numerous researchers have investigated hydrogels for 
biomedical and pharmaceutical applications, including tissue engineering [24], molecular 
imprinting [25], wound dressing [26], immunizations [27], and drug delivery [28,29]. 
Responsive hydrogels have remarkable advantages for controlled release because their 
volumes can change predictably in response to a variety of physical and chemical stimuli. 
Physical stimuli include temperature, electric or magnetic field, light, pressure, and 
sound, while chemical stimuli include pH, solvent composition, ionic strength, and 
specific molecular species such as glucose [28]. Because tissues and pathological 
conditions vary in physiological pH, pH-responsive polymeric materials have been 
studied extensively for site- and disease-specific drug delivery applications [29,30]. pH-
sensitive hydrogels can be categorized as anionic and cationic. Anionic or acidic 
hydrogels contain acidic side chains that become ionized, when the pH of the external 
swelling medium exceeds the pKa of the side chain [31]. Conversely, the amino side 
chains of cationic or basic hydrogels become ionized [32] when the external pH is lower 
than pKa of the side chain. Both types of pH-sensitive hydrogel can be useful for drug 
delivery under specific circumstances.  
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For this project, we will focus on acidic side chain hydrogels, which also contain the 
neutral comonomer, N-isopropylacrylamide (NIPA). NIPA is hydrophilic below 32 
degrees Celsius (oC). At 32 oC, the lower critical solution temperature (LCST), the 
hydrogel transitions from a hydrophilic to a hydrophobic entity [33]. Therefore, at 
physiological temperature (37 oC), NIPA will exhibit hydrophobicity. In order to explain 
this phenomenon, several scientists have used calorimetry to shown that the phase 
transition is governed by cooperative dehydration of poly(NIPA) chains [34]. Recently 
dielectric relaxation has been used to analyze the relaxation frequency [35]. The phase 
transition was associated with the complete dehydration of poly(NIPA) chains and the 
consequent generation of bare polymer chains at the LCST. The dielectric relaxation 
technique further revealed 11 water molecules per poly(NIPA), which strongly supported 
they hydrogen bond theory (figure 3.1). This transition is manifested in the discrete 
changes that occur in the mechanical, permeability and optical properties of poly(NIPA) 
hydrogels. 
 
Figure 3.1 Phase transition of poly(NIPA) at LCST [35]. 
Methacrylic acid (MAA) is a carboxylic acid which, when copolymerized with NIPA 
(Figure 3.2), endows the hydrogel with pH sensitive properties. The poly(NIPA-co-
MAA) hydrogel network has both pH and temperature sensitive characteristics [33]. 
Similarly, poly(NIPA-co-MAA) is expected to have an LCST where the phase transition 
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takes place by breaking hydrogen bonds and losing water molecules. The side chains of 
poly(NIPA-co-MAA) further affects the LCST under different pH values due to the 
changes in their hydrophilicity. 
 
Figure 3.2 Chemical structure of Poly (NIPA-co-MAA). 
According to a previous study [36], a 9:1 molecular ratio of the NIPA and MAA 
monomers produces hydrogels with a large linear swelling ratio (Figure3.3).  
 
Figure 3.3 pH-dependent equilibrium swelling studies at 37 oC, swelling transition 
magnitude and critical pH depends on MAA content [36, 37]. 
However, increasing the percentage of MAA molecules during the synthesis reduces the 
mechanical strength of the hydrogel [37]. Since the swelling ration is considered one of 
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the most important property, the 9:1 NIPA to MAA ratio was chosen to create the 
polymer for a pulsatile drug delivery system. 
In order to increase the mechanical strength of the hydrogels, we introduce nanoclay as 
crosslinker. Laponite XLG (diameter 25nm and thickness 0.92nm) consists of negatively 
charged silicate nano-discs with slightly positively charged edges. The lamellar sheet 
structure, when dispersed in water, swells into a house-of-cards structure by stacking on 
top each other due to the opposite charge on the surfaces and edges (Figure 3.4 A). 
 
 
Figure 3.4 Schematic of  nanoclay crosslinked poly(NIPA-co-MAA) synthesis. A) 
Schematic of laponite XLG nanoclay suspension and the house-of-cards structure: (a) 
clay, (b) clay platelets dispersed in water, and (c) house-of-cards structure. B) Schematic 
of Poly (NIPA-co-MAA) synthesis.The blue circles represent MAA and NIPA for 
synthesis in (a)-(e). (a) shows house-of-card structure has been decomposed after NIPA 
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comes in. (b) illustrates KPS and TEMED complexed with clay discs after added in. (c) 
shows radical formation near the clay surface (d) exhibits formation of clay-brush 
particles. (e) polymer network formation [38]. 
In previous work, our laboratory has utilized poly(NIPA-co-MAA) hydrogels that were 
crosslinked with BIS. These organically crosslinked hydrogels are mechanically weak. In 
the past two decades, it has been shown that NIPA containing hydrogel can be 
strengthened by using exfoliated laponite clay as a crosslinker [36]. Such hydrogels also 
exhibited superior optical and phase transition properties [39,40]. In the present chapter, 
we investigated the permeability properties of laponite crosslinked hydrogels. 
3.2 Materials and Methods 
3.2.1 Materials 
NIPA (monomer; Sigma-Aldrich) was recrystallized from hexane under vacuum at room 
temperature. MAA (monomer; Sigma-Aldrich) was purified by passing though activated 
alumina (Sigma-Aldrich) to remove inhibitor. The molar feed ratio of the comonomers 
was 9:1 NIPA/MAA. Laponite XLG (nanoclay cross-linker, Rockwood), N,N,N’,N’-
tetramethylethylenediamine (TEMED, accelerator: Sigma-Aldrich), sodium 
pyrophosphate decahydrate (SPP, ionic dispersant: Sigma-Aldrich) and potassium 
persulfate (KPS, initiator: Sigma-Aldrich), were used as received. The deionized (DI) 
water was ultrasonically degassed, and the gas bubbles were removed by vacuum.   The 
degassed water was used to synthesize the hydrogel. Chlorotrimethylsilane (Sigma-
Aldrich) was used for silanizing glassware. Acetate buffer (pH=3.5-5.5) and phosphate 
buffer (pH=6-8) were prepared to cover the entire range of swelling studies. Paracetamol 
(Sigma-Aldrich), caffeine (Sigma-Aldrich) and Lissamine Green B (LGB, dye; Sigma-
Aldrich) were used as solutes in the permeability experiments. 
 32 
3.2.2 Copolymerization of NIPA with Comonomers 
The anionic copolymer hydrogel, poly(NIPA-co-MAA), was synthesized using redox 
initiated free radical polymerization of NIPA and MAA at 5oC for 24 hours. All reagents 
and respective quantities are listed in Table 3.1. 
Table 3.1 Copolymerization of NIPA with MAA. 
materials MW 
(g/mol) 
Amount 
(µl) 
Amount 
(g) 
Molar  
ratio 
Amount 
(mmol) 
N-isopropylacrylamide(NIPA) 113.16  0.2 90 1.767×10-3 
Sodium pyrophosphate 
decahydrate (SPP) 
446.07  0.075  1.68×10-4 
Methacrylic acid(MAA) 86.6 17 0.017 10 1.96×10-4 
Clay(x-linker)   0.088   
Potassium persulfate (20mg/ml)  675 0.0135   
Tetramethylenediamine(TEMED)  116.20 5    
DI water (degassed)   2.13   
 
The Laponite clay was dispersed under stirring in pre-degassed deionized water to form 
an exfoliated and uniform dispersion of clay, which is a clear sol. Previously 
recrystallized NIPA monomers were then added. SPP was dissolved to prevent clay 
particle flocculation prior to adding MAA [36]. The reaction vessel was placed under 
inert nitrogen to exclude oxygen. MAA solution was then added dropwise into the 
mixture. Initiator, KPS, and catalyst, TEMED, were added together under bubbling 
nitrogen. To form the hydrogel with a membrane shape, the final mixture was injected 
between silanized glass plates separated by 100 µm gaskets. Solution polymerization 
took place at under 5oC for 24 hours. Thereafter, the gel was incubated in deionized water 
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to remove unreacted monomer. Lastly, the finished hydrogel was placed in saline 
conditioning medium.  
3.2.3 Equilibrium Swelling Studies 
In the pH-dependent equilibrium swelling studies, poly(NIPA-co-MAA) disks were 
equilibrated in several pH buffers at 37oC. Disk diameters were measured by a Vernier 
caliper over 60 minutes under different pH environments. The linear swelling ratio (LSR) 
was calculated by equilibrium swelling diameter at a given pH divided by 1.5cm which is 
the initial diameter of hydrogel. Swelling measurements were repeated three times and 
reported with error bars representing the standard deviation.   
In the shrink ratio studies, hydrogel equilibrated in pH 7 buffer at 37oC several hours 
before exposure to different pH buffers. In the swell ratio studies, hydrogel equilibrated 
in various pH buffers at 37oC several hours before exposure to pH 7 buffer. The hydrogel 
diameters were checked at 2, 5, 7, 10, 12, 15, 20, 30 and 60 minutes. 
3.2.4 Mechanical Properties 
Tensile moduli and strength of hydrogels were measured using a tensile tester (MTS 
Criterion Model 42). Hydrogel samples were first prepared in strips of 5cm x 1cm x 
100µm and stored in buffer at 37oC for an hour. Tensile measurements were performed at 
25oC with gauge length of 15mm and crosshead speed of 100mm/min. 
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3.2.5 Drug Permeability Studies 
 
Figure 3.5 Prototype for poly(NIPA-co-MAA) permeability studies. 
The setup for measure permeability of molecule through the hydrogel is illustrated in 
Figure 3.5.  LGB was the test solute for the permeability studies. The hydrogel membrane 
disk was first stored at pH 4 for 12 hours to achieve equilibrium in the shrunken state. 
Then the hydrogel was glued to the mouth of a centrifuge tube (diameter 1.5cm), which 
was cut on the other end to form a cylindrical tube.  The tube was submerged in a DI 
water tank overnight to swell the hydrogel. Before the permeability studies, a tube with 
the sealed hydrogel membrane was submerged in pH 7 buffer outside the tube and filled 
by pH 5.5 buffer for 4 hours to establish a pH gradient. A 37oC water jacket beaker was 
used to control temperature. At the beginning of the test, 12mg model drug in 3ml pH 5.5 
buffer was introduced into donor cell. The buffer in donor cell was changed each hour, 
which had a different pH but the same concentration of model drug. The receptor cell 
contained 150ml drug-free pH 7 phosphate buffer. The receptor cell was magnetically 
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stirred at 200rpm. Fresh drug-free phosphate buffer (pH 7) was renewed every hour. 
Receptor drug solution was passed through a UV-Vis spectrophotometer cuvette and 
returned to the receptor at the rate of 1ml/min. The absorbance of LGB was determined at 
633nm. 
Before the permeability studies, a tube with the sealed membrane were placed in pH 7 
buffer on both sides for 2 hours. Absorbance was monitored by UV-Vis in the absence of 
drugs. In this blank control experiment, the change in absorbance of the solution was 
negligible (data not shown).  
3.2.6 Phase Properties 
The hydrogel pieces weighing approximately 20mg were prepared by submerging in 
several buffers overnight. Then the peripheral solution was removed prior to running the 
experiment. Thermogravimetric analysis (TGA) was used before differential scanning 
calorimetry (DSC) to determine the decomposition weight percentage and temperature. 
The temperature range examined for both instruments was 20-50°C, using a rate of 
2°C/min.  
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3.3 Results 
3.3.1 Equilibrium Swelling Studies 
 
Figure 3.6 Poly(NIPA-co-MAA) linear swelling ratio with pH (a,b) and time (c,d). The 
shrinking and swelling ratio stands for the final diameter of hydrogel against the starting 
diameter for each test under respective pH.  
The hydrogel in the swollen state appeared transparent, but was opaque (white) in the 
shrunken state. The hydrogel shrinks from the swollen state when pH dropped below 5 
and the hydrogel swells from the shrunken state when pH rises above 5. The shrinking 
and swelling of the hydrogen took around 10 minutes to complete, regardless of pH.  
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3.3.2 Mechanical Properties 
 
Figure 3.7 Tensile strength of the Poly (NIPA-co-MAA) hydrogel under pH 3.5 to 6.5. 
Strain percentage is the deformation ratio of material in continuous mechanics. Strain% = 
elongation /original length. 
As shown in Figure 3.7, the hydrogels were highly elastic. Under pH 3.5-4.5, the 
hydrogel exhibited the highest mechanical strength but the lowest strain at the break 
point. The hydrogel under pH 5.5-6.5 shows the opposite properties, with the lowest 
mechanical strength and the most elongation before break. At pH = 5, the hydrogel 
exhibited intermediate mechanical strength and elongation at break. 
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3.3.3 Drug Permeability Studies 
  
Figure 3.8 LGB permeability through the hydrogel membrane at different pH 
environments. Orange dashed line stands for pH in the donor cell. Blue line stands for 
accumulated absorbance of LGB in the receptor cell. Black dash line provides visual 
contrast between permeabilities in shrunken and swollen states of the hydrogel 
membrane. 
The flux of LGB across the poly(NIPA-co-MAA) in response to a down-up staircase of 
pH values in the donor cell, is recorded in Figure 3.8. The absorbance of the LGB 
indicator was detectable at 15 minutes and remained detectable throughout seven hours. 
The permeation rate is quantified by the change in test solute concentration in the 
receptor side as a function of times. The LGB permeated through the hydrogel most 
rapidly during the first two hours when pH was between 5.0 and 5.5. When the pH was 
decreased from 5.0 to 4.5, the permeation become slower. However, the permeation 
increased when the pH was increased from 4.5 to 5.0. The nonlinear parts of the 
permeability curve are due to lag in the membrane shrinkage and swelling time. 
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3.3.4 Phase Properties 
 
Figure 3.9 Heat flow of poly(NIPA-co-MAA) under different pH environments. To 
minimize the effect of water evaporation on the heat flow, the temperature was limited to 
50 oC. 
Thermal phase properties of the poly(NIPA-co-MAA) hydrogels are shown in figure 3.9. 
The curves for pH 4.5 and 5 show an endotherm during temperature increase. At the 
temperature where the energy absorption occurred, water likely separates from the 
polymer, leading to two phases corresponding to LCST behavior.  
The poly(NIPA-co-MAA) hydrogel showed an LCST at 36.9oC after pH = 4.5, and an 
LCST at 42oC for pH = 5 as indicated by the obvious valleys. When pH = 5.5, there was 
no obvious critical temperature but the heat flow curve diminished gradually. There was 
no obvious phase transition when pH=7. The results suggest that at 37oC, physiological 
temperature, hydrogel is in the shrunken state under pH = 4.5 and in swollen state under 
pH = 5. For hydrogel in pH 5.5 buffer, there was no obvious LCST curve shows even 
when the range was extended to 90oC.  
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3.4 Discussion  
3.4.1 Equilibrium Swelling Studies 
As expected, hydrogels swelled at higher pH and shrink at lower pH values. However, as 
can be noted from Figure 3.6 a) and 3.6 b), there was a pH shift in the transition region 
depending on whether the hydrogel began in the swollen versus the shrunken state. This 
observation is indicative of hysteresis in swelling with respect to pH. Such hysteresis is a 
desirable property when the hydrogel membrane is included in the oscillator, described in 
chapter 4. It is also remarkable that, swelling or shrinking equilibrium were achieved 
typically within 10 minutes, which is also desirable with respect to the proposed 
oscillator. 
3.4.2 Mechanical properties 
In the study, hydrogels containing Laponite clay were used due to their reported superior 
mechanical properties, compared to conventional organically crosslinked hydrogels. 
Robust mechanical properties are needed, since in an oscillator, the hydrogel must 
undergo repetitive cycles of swelling and shrinking, without membrane breakage. It was 
found that the swollen state (high pH) is weaker but had a higher strain at the break point 
than the shrunken state (low pH).  
3.4.3 Drug Permeability Studies 
The permeability study was carried out to facilitate the prediction of the drug release 
through hydrogel under various pHs. We expected high permeability under high pH 
conditions when the hydrogels swell and much lower permeability under low pH 
conditions when the hydrogel is shrunken. The release profile we expected is the 
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hydrogel have high permeability in swollen state but completely impermeable in 
shrunken state. Although the slope of release profile (Figure 3.8) changed with pH, the 
difference was less than anticipated.  
Interestingly, the LGB permeated at the highest rate during the first hour when the pH 
dropped from 5.5 to 5. Between 5 and 7 hours, the slope of LGB accumulation appears 
less steep than the first 2 hours, even though the pH remains in the same range. One 
explanation could be the buffering effect near the top and bottom sides of the hydrogel 
membrane. More specifically, the ion exchange near both sides of the membrane may 
influence the local pH environment and potentially affect the measured permeability of 
LGB. The microenvironment around membrane is difficult to determine, especially the 
hydrogel ion concentration.  
3.4.4 Phase properties  
Hydrogel consist of poly(NIPA) are known to exhibit LCST behavior in water. They 
swell for temperatures at and below 32oC and shrink above that temperature. By adding 
MAA to the hydrogel chains, the poly(NIPA-co-MAA) hydrogel’s LCST also becomes 
pH dependent, as was shown in our DSC experiment (Figure 3.9). Therefore, if the 
temperature is fixed at 37oC, the hydrogel will be above LCST at pH 4.5 but below LCST 
at pH 5, hence shrunken at pH 4.5 but swollen at pH 5.  
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Chapter 4 Rhythmic Delivery System 
4.1 Introduction 
 
A delivery system that provides rhythmic release of hormones, powered by constant 
glucose concentration was developed [13-15]; however, there are several shortcomings 
with room for improvement.  
First, marble plays a critical role, but due to the low membrane surface to chamber 
volume ratio, it takes a long time for hydrogen ion to exit cell II and diffuse out of the 
hydrogel membrane. Marble acts to eliminate the hydrogen ions produced by glucose and 
thereby increases the rate of the pH changes. The collapse and swelling behavior at 
different pH values in this system exhibits bi-stability property and hysteresis, which is 
active in promoting oscillations. Marble also promotes oscillations, and in its absence, the 
membrane may be trapped in an intermediate permeability state. Here, there is a steady 
state balance of glucose influx, enzymatic conversion and hydrogen clearance, and no 
oscillations occur in the pH of Cell II. 
The current system also has a significant drawback in maintaining a regular drug release 
cycle through the pH oscillations. As the marble neutralizes the protons generated by 
glucose metabolism, its surface area decreases, and consequently the rate of proton 
removal and associated pH oscillations in Cell II are slowed. The accumulation of the 
byproduct CaCl2 from the marble also correlates with slowing of the oscillation cycle. In 
addition, the surface area of the marble, which is a critical parameter in determining 
oscillating behavior [14], will slowly decrease and eventually the marble is depleted.  
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Moreover, for an implantable release system, additional restrictive factors need to be 
considered. First, the size of the device, 80ml fluid (Cell II) wrapped in a 400 µm-thick 
membrane, is simply too large to implant into the central nervous system. Second, the 
glucose-driven oscillation is unrealistic in a physiological environment. The “outside 
physiological” glucose concentration was optimized at 50 mM, which is 7 to 12 times the 
actual human glucose level (4-7mM). Additionally, the marble contributes too much 
mass to the drug delivery system. Moreover, the integrity of the hydrogel membrane may 
not be maintained, when in contact with the rough and uneven surface of the marble. 
In order to transform the original system into a more practical device amenable for use in 
vivo, we reduced the Cell II volume size and removed the marble. We assume the 
hydrogen ions in the membrane diffuse into Cell I and are replaced by the remaining H+ 
in Cell II causing pH in Cell II revert. To increase the hydrogen ion (i.e. pH) dynamics in 
Cell II and the membrane swell/shrink rhythmic changes in the membrane, we increase 
the ratio of the membrane area to volume of Cell II [16]. 
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4.2 Materials and Methods 
 
Figure 4.1 New prototype for implantable hormone release system. a) old horizontal 
prototype [14]. b) New vertical prototype. The self-assembled pH stat from Chapter 1 is 
connected with Cell I which mimics the physiological environment. Enzyme mixture 
colored by green in Cell II. Cell II is bathed in the solution in Cell I and is connected with 
Cell I only through the hydrogel layer at the bottom of the tube. Purple part exhibits 
circulating fresh glucose media in Cell I.  
 
The experimental setup of the new prototype is a vertical transport cell as shown in 
Figure 4.1. To prime the system, 3mL of glucose-free pH 4.4 HCL buffer was added into 
Cell II to maintain the shrunken state of the hydrogel. Meanwhile, glucose-free 50mM 
saline of pH 7.0 was placed into Cell I, whose volume was 150ml. The 1.77 cm2 
(diameter 1.5cm) circular semipermeable hydrogel, poly(NIPA-co-MAA) presented in 
Chapter 3, was exposed to both cells. The hydrogel membrane separating Cell I and Cell 
II was secured on the centrifuge tube (Cell II) by sealing glue (Gorilla) and sealed by 
parafilm to avoid any leakage and contamination. Priming of the system took place for 3 
hours. The pH gradient environment stability was maintained by pH stat in Cell I. Cell II 
was stirred by an overhead paddle and Cell I was mixed by a magnetic stirrer (200rpm). 
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After the pH gradient stabilized, various concentrations of glucose in 50mM saline were 
recirculated with Cell I at 1ml/min by a peristaltic pump. Fresh pH=4.4 enzyme solution, 
glucose oxidase from aspergillus niger (Sigma 225970U/mg) and catalase (Sigma 
7741IU/mg), with trace amounts of gluconolactonase) replaced the buffer solution in Cell 
II. Thereafter, two pH meters recorded data every one minute in Cell I and Cell II. 
Meanwhile, the pH stat designed in Chapter 1 maintained the pH in Cell I at pH 7.0.  
Due to the high cost of GnRH, we did not accurately track the drug release profile. The 
drug release condition is reflected by the pH inside Cell II and membrane swelling state, 
which is showed in Chapter 2. More specifically for drug rhythmic delivery in this 
system, when the pH higher than 5 in chamber II, the membrane is in a swollen state and 
the cumulative drug release is fast. Conversely, at pH less than 5, drug release is slow due 
to the collapsed state of the membrane. 
4.3 Results 
 
Figure 4.2 Ten independent oscillation experiments with various glucose concentration in 
Cell I. 
Figure 4.2 depicts the pH as a function of time for ten separate 20-hour pH recordings in 
the pulsatile drug delivery system. pH oscillations were not observed under any glucose 
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concentration. The saline control aimed to establishes the rate of hydrogen ion release 
from the membrane at Cell II. The graph shows that the hydrogen ion transports through 
the hydrogel membrane in less than two hours. With different glucose concentrations in 
Cell II, each run shows constant intermediate pH by the influence of glucose 
concentration from 0-40mM. At higher glucose concentrations in this range for Cell II, 
the pH decreased. Once the concentration of glucose reached 50mM and higher, the pH 
value of Cell II stabilized around 5.5-6, regardless glucose concentrations. In all cases, 
the Cell I pH was maintained around 6.5-7 by the pH-stat. 
4.4 Discussion 
 
Our Study was unable to show pH oscillations in Cell II as proposed under the various 
glucose concentration environments as proposed. Our finding is not consistent with the 
theoretical predictions reported in the literature [16]. The previous study theorized that 
the hydrogel membrane would act as a semipermeable barrier to allow glucose transport 
when swollen (pH > 5) and block glucose transport when shrunken (pH < 5). Once 
glucose from the physiological environment (Cell I) enters the implantable device (Cell 
II), it will be converted by enzymes to produce hydrogen ions. Then, the hydrogen ions 
are expected to lower the pH in Cell II and be attracted to the negatively charged 
hydrogen membrane to transform it from being swollen to shrunken. As a result, the entry 
of glucose to Cell II is temporarily blocked by the shrunken hydrogel. The hydrogel will 
become permeable again once hydrogen ion in Cell II crossed the membrane to Cell I 
where pH is regulated by pH stat. The pH oscillation in Cell II would take place when all 
the steps are fulfilled as described. However, this sequence of events was not observed in 
our system. 
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At this point, we believe that theoretical approach is sound, and the experimental failure 
arose from inappropriate assumptions. Because more than one variable was changed to 
optimize the system for in vivo use, it is not possible to determine which experimental 
parameter is the root cause or even if there are more than one parameter giving rise to the 
failure. As such, there is a need to back track and take a systematic, step by step 
approach.  
Specifically, the same oscillation patterns in the original setup must be reproduced [14], 
in which the home designed pH-stat for the commercial autotitrator introduced in Chapter 
2 is used. With success, the second step would be to replace the organically crosslinked 
poly(NIPA-co-MAA) membrane with our laponite-crosslinked membrane, still using the 
original setup. This systematic approach could reveal the problems, without introducing 
extra variables such as volume of Cell I, surface area of the membrane, and the removal 
of marble from the system. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 48 
Chapter 5 Conclusions and Future Directions 
5.1 Conclusions 
We successfully programmed the pH stat able to perform well for the project. The poly 
(NIPA-co-MAA) hydrogel’s swelling ratio, mechanical strength, permeability and phase 
properties were characterized. A new prototype of the GnRH rhythmic delivery system 
was examined, but did not function as required. 
5.1.1 pH Stat 
The self-assemble pH stat is economical and easy to control. The pH controller is suitable 
for most titration conditions with model and hardware adjustment. The peristaltic pumps 
are adaptable for accurate dosing applications with a variety of tube size and pump ratios 
available. The theoretical acid-base equilibrium equation-based program is applicable to 
any titration program; however, the empirical model-based program provides more rapid 
response. 
5.1.2 pH-Sensitive Hydrogel 
The 100 µm nanoclay cross-linked poly (NIPA-co-MAA) was synthesized successfully. 
The equilibrium swelling ratio, mechanical properties, drug permeability under various 
pH environment and phase properties were presented.  The equilibrium swelling studies 
provided guidance for the measurable permeability variations over a range of pH value. 
The mechanical studies showed that the hydrogel was strongest in the shrunken state. The 
phase properties reflect LCST behavior. The permeability provided the pH drug release 
profiles, which did not vary to the extent required for a pulsatile system.  
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5.1.3 Rhythmic Delivery System 
The new prototype for the implantable pH-oscillator rhythmic hormone release system 
was assembled but did not produce the intended pH oscillations. Various glucose 
concentrations for oscillation experiments were attempted, but they all result in a 
constant, steady state pH behavior.  
5.2 Future Directions 
5.2.1 pH-Stat 
The peristaltic pump and tubing hardware are easy to adjust for high customizability. 
Beyond that, for future more precise titrations, more data can be obtained by manual 
titration, and better calibration curves can be determined.   
5.2.2 pH-Sensitive Hydrogel 
A therapeutic system which can resist abrasion in the target organ or site is required. 
Poly(NIPA-co-MAA) crosslinked by acylated allylic starch could be used to replace of 
the nanoclay-crosslinked hydrogels. The high tensile properties and swelling ratio have 
demonstrated for such system [41]. In addition, the potential complication due to the 
ionized nanoclay particles would be eliminated in the starch-crosslinked system [36]. 
5.2.3 Rhythmic Delivery System 
As a future step in constructing a pulsatile delivery system, the enzyme could be 
entrapped or be covalently linked into the hydrogel matrix [42]. The size of the hydrogel 
capsule (Cell II) can reduced, since the volume of its contents is smaller by localizing the 
enzymes in the hydrogel membrane. By reducing the need for glucose to cross the 
hydrogel membrane, this design can allow glucose molecules to be better taken up by the 
enzymes. Cell II will likely become more sensitive to glucose concentration, given that 
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the enzymes will encounter glucose molecules on the surface of the hydrogel capsule. 
Buffer byproducts of the glucose metabolism would diffuse away from the membrane in 
the shrinking process [43-45]. As a result, the pH oscillation in Cell II will be strictly 
regulated by glucose conversion. The previous concern of increased oscillation cycle 
caused by buffer buildup will likely be resolved [14]. It will be easier for plasma oxygen 
take part in the enzyme metabolism, and therefor we can overcome the oxygen 
consumption problem. Once the oscillation challenge is overcome, we shall proceed to 
study the drug release features of the system. 
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